PDIA6 silencing decreased cell survival and increased apoptosis; PDIA6 vaccination of mouse model decreased tumor growth by 43%; autoantibodies to PDIA6 elevated in sera from DCIS and invasive patients with breast cancer compared with controls, also in fibroadenoma condition. This evidence concerns the gene PDIA6 and breast carcinoma.